Psychedelic Stocks Archives - Page 49 of 61

ThursdayJun 23, 2022 10:41 am

Four Psychedelics ETF Investors Are Interested In

Renewed interest in psychedelics in both public and scientific spaces has increased investor interest in psychedelic stocks. The psychedelic market is projected to achieve a valuation of $10.7 billion by 2027, and investors are looking to cash in on the industry before it is saturated. However, the industry is still in its infancy and presents a high degree of risk. As such, psychedelic ETFs or exchange-traded funds that allow investors to buy a bundle of several stocks rather than one have been the focal point of investor interest as they allow diversified risk. Below are a couple of ETFs investors…

WednesdayJun 22, 2022 3:47 pm

Study Finds Frequent Nightmares May Be Sign of Parkinson’s Disease Development

Are you an older man who has been experiencing regular nightmares as you age? A new study suggests that this may be an early warning sign of Parkinson’s disease. Parkinson’s is a brain disorder that causes uncontrollable movements and makes it increasingly difficult for patients to talk and walk in its advanced stages. With at least one-quarter of patients suffering from Parkinson’s reporting that they experience upsetting dreams regularly, scientists have spent the last few years investigating the link between Parkinson’s and sleep. This new study, which is the first of its kind, was designed to investigate whether developing nightmares…

TuesdayJun 21, 2022 10:46 am

Advances in Precision Medicine Boost Research on Psychedelics

Precision medicine is a relatively new field in medical technology that has allowed doctors to peer even deeper into the human body, thus broadening the horizons of medical treatments significantly. This groundbreaking technology is now being paired with psychedelics to boost psychedelic research and development. At the moment, however, most psychedelic research is centered on how these substances target and affect the serotonin 2A receptor in the brain. This receptor is associated with neuropsychiatric disorders and mental health conditions such as post-traumatic stress disorder (PTSD) and chronic depression, and the receptor is often targeted during the treatment of such conditions.…

FridayJun 17, 2022 12:47 pm

Pennsylvania Veterans to Help Researchers Study Psychedelics as Trauma Treatment

In the state of Pennsylvania, a movement led by former members of the military has declared that there is an urgent need to make psychedelics widely available as a treatment for conditions such as severe depression and PTSD. The available treatments for mental health often aren’t effective, leaving veterans grappling with side effects, including muscle spasms and cramps, weight gain, and addiction. Prior studies have found that military veterans have an elevated risk of developing depression, post-traumatic stress disorder and traumatic brain injuries. Research conducted in 2018 found that 23% of veterans exhibited PTSD symptoms. With psychedelics seeing a resurgence…

ThursdayJun 16, 2022 4:00 pm

Mystical Experiences Due to Psilocybin Linked to Positive Mental Well-Being

Psychonauts have long talked about how profoundly psychedelics can affect your mental well-being, with many of these individuals revealing that psychedelics changed their lives. In recent years, psychedelics have seen a resurgence in popularity as more people use them recreationally, for medical purposes and as part of their spiritual journeys. Now new research has found that hallucinogens, specifically psilocybin, may have positive long-lasting psychological effects. Drummond E-Wen McCulloch, author of the new study, wrote that in some individuals a medium to high dose of psilocybin could cause profound alterations in consciousness. McCulloch explained that this was often accompanied by dissolution…

WednesdayJun 15, 2022 1:00 pm

What You Should Know About Ego Death

Everyone has experienced it at least once in their lives: you walk into a room with purpose only to realize you have no idea what you came for. You stare at the room, racking your brain for information, but all you draw is a blank. This state of temporary amnesia is the concept behind ego death. Also referred to as ego dissolution, this term has been used in mystic and psychedelic communities for decades to describe a state of temporary autobiographical amnesia. Think of that moment of brain fog stretching over time, leaving you floating in a cloud of nothingness…

TuesdayJun 14, 2022 3:58 pm

British Columbia Moves to Decriminalize Possession of Various Drugs

Last month, the province of British Columbia received permission from the federal government to decriminalize the possession of various drugs. This news from the province, which is home to roughly 5 million individuals, was announced by the minister of Federal Mental Health and Addictions, Carolyn Bennett. The measure’s objective is to help alleviate the opioid overdose crisis, which has affected this particular province greatly. The new regulations, which will decriminalize the use and possession of illegal substances such as fentanyl and heroin, will come into effect on January 31, 2023. It should be noted that the sale and distribution of…

MondayJun 13, 2022 2:01 pm

Five Books on Psychedelics You May Enjoy Reading

Psychedelics have been seeing a resurgence in popularity over the past couple of years, thanks to their purported medical abilities. Several studies have also found that psychedelics such as LCD and ketamine can be used to treat substance abuse and mental health disorders, including depression, anxiety and even post-traumatic stress disorder (PTSD). If you would like to learn more about psychedelics, there is plenty of material available for you to dig into. Here are some books to start you off if scientific reports aren’t your thing. “LSD, My Problem Child: Reflections on Sacred Drugs, Science and Mysticism” This book was…

FridayJun 10, 2022 12:17 pm

Four Key Takeaways from the Catalyst Summit in Canada

A couple weeks ago, a psychedelic conference known as the Catalyst Summit was held in Ontario. Representatives of Health Canada, politicians, researchers and leaders of psychedelic drug companies as well as trained therapists and patients who had gained benefit from psychedelic drugs gathered together. Various panel discussions were held, some of which focused on how psychedelics could be used to treat a range of mental health conditions. As researchers learn more about these drugs and more studies on their effectiveness are conducted, the substances get one step closer to getting legalized. Given that it is only a matter of time…

ThursdayJun 09, 2022 3:35 pm

New Study Suggests That MDMA May Decrease Fear, Boost PTSD Treatment

A new study that looked into the relationship between an individual’s response to fear and the use of MDMA has found that combining this drug with recall therapy and fear extinction learning substantially decreased the fear felt by individuals involved in the study. This comes after MAPS recently released promising results from its phase III clinical trial, which found that MDMA-assisted therapy could be beneficial to patients with PTSD. The MindMed-linked research was carried out by scientists based at the University Hospital of Basel, which is located in Switzerland. Their objective was to test whether the use of MDMA could…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks